Skip Nav Destination
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma
Clin Cancer Res (2021) 27 (23): 6424–6431.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Laurie Graves
- William R. Jeck
- Juneko E. Grilley-Olson
Current Treatment Options in Oncology (2023)
- Pampina Pilavaki
- Myrofora Panagi
- Samia Arifi
- Robin L. Jones
- Triantafyllos Stylianopoulos
- Anastasia Constantinidou
Frontiers in Oncology (2023) 12
- Zhichao Tian
- Shuping Dong
- Yang Yang
- Shilei Gao
- Yonghao Yang
- Jinpo Yang
- Peng Zhang
- Xin Wang
- Weitao Yao
BMC Cancer (2022) 22 (1)
- Zhichao Tian
- Weitao Yao
Frontiers in Immunology (2022) 13
- Lauren B. Banks
- Sandra P. D’Angelo
Journal of the National Comprehensive Cancer Network (2022) 20 (7): 834.
- Meghan M. Lynch
- Borislav A. Alexiev
- Brett A. Schroeder
- Seth M. Pollack
Current Treatment Options in Oncology (2022) 23 (12): 1861.
- Tarek Assi
- Olivier Mir
Immunotherapy (2022) 14 (5): 271.
- Zhichao Tian
- Shuping Dong
- Wenli Zuo
- Po Li
- Fan Zhang
- Shilei Gao
- Yonghao Yang
- Chao Li
- Peng Zhang
- Xin Wang
- Jiaqiang Wang
- Weitao Yao
Frontiers in Pharmacology (2022) 13
- Cristiam Moreno Tellez
- Yan Leyfman
- Sandra P. D'Angelo
- Breelyn A. Wilky
- Armelle Dufresne
Surgical Oncology Clinics of North America (2022) 31 (3): 381.
